Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease (Q81381423)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2006
edit
Language Label Description Also known as
English
Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
scientific article published on 01 January 2006

    Statements

    Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit